The University of Chicago Header Logo

Alexander Pearson

Concepts (385)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
18
2023
1059
2.820
Why?
Neoplastic Stem Cells
10
2021
142
1.530
Why?
Neoplasms
12
2023
2809
1.480
Why?
Carcinoma, Squamous Cell
8
2022
1079
1.460
Why?
Medical Oncology
4
2023
350
1.420
Why?
Artificial Intelligence
6
2023
261
1.340
Why?
Salivary Gland Neoplasms
6
2021
65
1.320
Why?
Oropharyngeal Neoplasms
4
2022
124
1.300
Why?
Papillomavirus Infections
4
2022
242
1.180
Why?
Carcinoma, Adenoid Cystic
5
2018
28
1.160
Why?
Hematology
1
2023
29
0.940
Why?
Endocrine Gland Neoplasms
1
2022
6
0.930
Why?
Biomarkers, Tumor
6
2022
1450
0.920
Why?
Carcinoma, Non-Small-Cell Lung
3
2023
1063
0.910
Why?
Lenses
1
2022
4
0.890
Why?
Drug Resistance, Neoplasm
6
2019
582
0.890
Why?
Medicine
1
2022
87
0.850
Why?
Carcinoma
2
2022
431
0.840
Why?
Humans
77
2023
84431
0.830
Why?
Lens, Crystalline
1
2022
68
0.830
Why?
Diagnostic Tests, Routine
1
2021
62
0.800
Why?
Carcinoma, Papillary, Follicular
1
2020
13
0.800
Why?
Specimen Handling
1
2021
96
0.790
Why?
Academies and Institutes
1
2020
30
0.780
Why?
Chemoradiotherapy, Adjuvant
1
2020
35
0.780
Why?
Otorhinolaryngologic Surgical Procedures
1
2020
17
0.780
Why?
Microsatellite Instability
4
2021
40
0.780
Why?
Ovarian Neoplasms
3
2022
723
0.760
Why?
Gene Expression Regulation, Neoplastic
6
2021
1196
0.750
Why?
Neurofibromin 1
1
2019
8
0.740
Why?
ras Proteins
1
2020
128
0.740
Why?
Proto-Oncogene Proteins B-raf
1
2020
136
0.730
Why?
Mouth Neoplasms
4
2023
196
0.730
Why?
Cyclin D1
1
2019
83
0.720
Why?
Radiotherapy, Adjuvant
1
2020
290
0.720
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2022
2401
0.720
Why?
Lung Neoplasms
3
2023
2235
0.710
Why?
Adenocarcinoma
3
2023
1155
0.710
Why?
Leadership
1
2020
130
0.700
Why?
Machine Learning
6
2023
215
0.670
Why?
Triple Negative Breast Neoplasms
4
2022
133
0.660
Why?
Cell Proliferation
8
2021
1566
0.650
Why?
Neoplasm Staging
7
2022
1929
0.640
Why?
Carcinoma, Mucoepidermoid
4
2019
17
0.630
Why?
Transcriptome
2
2021
559
0.620
Why?
Precision Medicine
1
2021
383
0.600
Why?
Patient Selection
1
2020
684
0.590
Why?
Mutation
6
2021
3904
0.580
Why?
Papillomaviridae
3
2022
156
0.580
Why?
Thyroid Neoplasms
1
2020
404
0.570
Why?
Breast Neoplasms
6
2022
2845
0.570
Why?
Image Processing, Computer-Assisted
2
2021
1195
0.570
Why?
Cell Line, Tumor
16
2021
2395
0.510
Why?
Xenograft Model Antitumor Assays
11
2021
455
0.490
Why?
Proto-Oncogene Proteins c-mdm2
3
2018
29
0.460
Why?
Interleukin-6
3
2020
244
0.440
Why?
Antineoplastic Agents
8
2022
2329
0.440
Why?
Tumor Burden
4
2022
280
0.400
Why?
Female
33
2022
43875
0.400
Why?
Stomach Neoplasms
3
2023
261
0.400
Why?
Neoplasm Recurrence, Local
9
2022
1262
0.390
Why?
Prognosis
7
2023
3626
0.380
Why?
Immunotherapy
8
2023
602
0.370
Why?
Mice
21
2021
11056
0.360
Why?
Tumor Microenvironment
6
2023
386
0.350
Why?
Neoplasm Grading
2
2020
346
0.340
Why?
Models, Biological
3
2022
1731
0.330
Why?
Estrogen Receptor alpha
2
2019
142
0.330
Why?
T-Lymphocytes, Regulatory
2
2021
288
0.320
Why?
Mice, SCID
6
2018
251
0.320
Why?
Cisplatin
6
2022
603
0.310
Why?
Middle Aged
19
2022
24746
0.310
Why?
Cyclin-Dependent Kinase 6
2
2017
13
0.300
Why?
Cyclin-Dependent Kinase 4
2
2017
28
0.300
Why?
Tumor Suppressor Protein p53
3
2018
370
0.300
Why?
B7-H1 Antigen
4
2023
243
0.300
Why?
Animals
25
2022
26192
0.300
Why?
Algorithms
4
2023
1812
0.290
Why?
Receptor, ErbB-2
4
2022
210
0.280
Why?
Gene Expression Profiling
2
2021
1362
0.270
Why?
Colorectal Neoplasms
3
2021
903
0.260
Why?
Neoplasm Proteins
2
2020
532
0.260
Why?
Receptors, Interleukin-6
2
2021
17
0.260
Why?
Paclitaxel
4
2022
459
0.250
Why?
Membrane Glycoproteins
2
2016
427
0.250
Why?
Proportional Hazards Models
3
2023
855
0.250
Why?
Antibodies, Monoclonal, Humanized
3
2020
918
0.240
Why?
Male
20
2022
40422
0.240
Why?
Xerostomia
1
2023
10
0.240
Why?
Mouth Diseases
1
2023
15
0.230
Why?
Oral Medicine
1
2023
4
0.230
Why?
Cohort Studies
5
2021
2717
0.230
Why?
Piperazines
3
2019
269
0.230
Why?
Drug Design
1
2023
123
0.230
Why?
Re-Irradiation
1
2022
16
0.220
Why?
Pyridines
3
2019
305
0.220
Why?
Uncertainty
1
2022
71
0.220
Why?
Polycomb Repressive Complex 1
1
2021
4
0.220
Why?
Lymphocytes, Tumor-Infiltrating
2
2020
123
0.210
Why?
Liquid Biopsy
1
2021
31
0.210
Why?
Cloud Computing
1
2021
7
0.210
Why?
Precancerous Conditions
1
2023
194
0.210
Why?
Data Accuracy
1
2021
28
0.210
Why?
Neoplastic Cells, Circulating
1
2021
69
0.210
Why?
Epstein-Barr Virus Infections
1
2021
47
0.200
Why?
Neoplasm Metastasis
3
2020
1054
0.200
Why?
Drug Monitoring
1
2022
118
0.200
Why?
DNA, Viral
1
2022
263
0.200
Why?
Cellular Reprogramming
1
2021
36
0.200
Why?
Hypopharyngeal Neoplasms
1
2020
15
0.200
Why?
Neck Dissection
1
2021
67
0.200
Why?
Cell-Free Nucleic Acids
1
2022
62
0.200
Why?
Endogenous Retroviruses
1
2020
9
0.200
Why?
Acetophenones
1
2020
27
0.200
Why?
Receptors, Progesterone
2
2019
165
0.200
Why?
Neoplasms, Experimental
2
2020
271
0.190
Why?
Poly (ADP-Ribose) Polymerase-1
1
2020
21
0.190
Why?
Recombinational DNA Repair
1
2020
9
0.190
Why?
4-1BB Ligand
1
2020
1
0.190
Why?
Neoplastic Syndromes, Hereditary
1
2020
18
0.190
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2020
15
0.190
Why?
Aged
11
2021
18157
0.190
Why?
Wnt Signaling Pathway
1
2021
87
0.190
Why?
Protein Kinase Inhibitors
3
2019
588
0.190
Why?
Actomyosin
1
2020
43
0.190
Why?
User-Computer Interface
1
2021
185
0.190
Why?
Laryngeal Neoplasms
1
2020
91
0.190
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2020
69
0.190
Why?
Genome, Mitochondrial
1
2019
26
0.180
Why?
DNA Mutational Analysis
1
2021
526
0.180
Why?
Naphthalenes
1
2019
45
0.180
Why?
TOR Serine-Threonine Kinases
1
2021
181
0.180
Why?
Retrospective Studies
6
2023
8152
0.180
Why?
High-Throughput Nucleotide Sequencing
2
2019
447
0.180
Why?
Treatment Outcome
7
2022
7829
0.180
Why?
Mitosis
2
2017
149
0.180
Why?
Diagnostic Imaging
1
2023
459
0.180
Why?
Cytoskeleton
1
2020
186
0.180
Why?
DNA, Mitochondrial
1
2019
182
0.170
Why?
Aromatase Inhibitors
1
2018
28
0.170
Why?
Quinolines
1
2019
94
0.170
Why?
Olfactory Mucosa
1
2018
33
0.170
Why?
Ataxia Telangiectasia Mutated Proteins
1
2019
50
0.170
Why?
Point Mutation
1
2019
246
0.170
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2020
135
0.170
Why?
Cell Adhesion
2
2020
416
0.170
Why?
Pyrrolidines
1
2018
55
0.170
Why?
Gene Rearrangement
1
2019
169
0.170
Why?
Gastrointestinal Neoplasms
1
2019
102
0.170
Why?
Indoles
1
2020
316
0.170
Why?
Lymphocyte Activation
1
2021
721
0.160
Why?
Students, Medical
1
2023
383
0.160
Why?
Oncogene Proteins, Fusion
1
2018
128
0.160
Why?
Prospective Studies
3
2023
4091
0.160
Why?
Proto-Oncogene Proteins
1
2021
645
0.160
Why?
Computational Biology
1
2021
527
0.160
Why?
Early Detection of Cancer
1
2021
375
0.160
Why?
Programmed Cell Death 1 Receptor
1
2019
153
0.160
Why?
Capecitabine
1
2017
87
0.150
Why?
Aldehyde Dehydrogenase
1
2016
14
0.150
Why?
Epigenesis, Genetic
1
2021
459
0.150
Why?
Logistic Models
1
2020
1168
0.150
Why?
Lymph Nodes
1
2020
534
0.150
Why?
Lymphocytes
1
2018
458
0.150
Why?
Gossypol
1
2016
6
0.150
Why?
Signal Transduction
6
2021
3198
0.150
Why?
Receptors, Estrogen
2
2016
378
0.150
Why?
Trans-Activators
1
2019
428
0.150
Why?
Protein Interaction Maps
1
2016
48
0.150
Why?
Time Factors
4
2020
5179
0.150
Why?
Salvage Therapy
1
2017
231
0.140
Why?
Image Interpretation, Computer-Assisted
1
2021
658
0.140
Why?
Immunoconjugates
1
2016
102
0.140
Why?
Retinal Dehydrogenase
1
2015
6
0.140
Why?
Disease Models, Animal
5
2021
2208
0.140
Why?
Taxoids
1
2016
129
0.140
Why?
Hyaluronan Receptors
1
2015
35
0.140
Why?
Biostatistics
1
2015
20
0.140
Why?
Cell Separation
1
2016
195
0.140
Why?
Aniline Compounds
1
2015
49
0.140
Why?
Risk Factors
3
2021
5312
0.130
Why?
Cell Division
1
2016
696
0.130
Why?
Statistics as Topic
1
2015
234
0.130
Why?
Chemoradiotherapy
3
2022
304
0.130
Why?
United States
3
2022
6473
0.130
Why?
Isoenzymes
1
2015
270
0.130
Why?
Microbiota
1
2020
367
0.130
Why?
Crohn Disease
1
2021
714
0.130
Why?
Brain Neoplasms
1
2020
755
0.130
Why?
Colitis, Ulcerative
1
2021
694
0.120
Why?
Tumor Cells, Cultured
1
2016
1041
0.120
Why?
Drug Synergism
3
2020
302
0.120
Why?
Risk Assessment
1
2021
2230
0.120
Why?
Cell Transformation, Neoplastic
1
2016
424
0.120
Why?
Neoplasm Transplantation
3
2020
393
0.120
Why?
Sulfonamides
1
2015
296
0.120
Why?
Adult
10
2022
25260
0.110
Why?
Disease-Free Survival
3
2022
1204
0.110
Why?
Receptors, Fibroblast Growth Factor
1
2011
16
0.100
Why?
Mice, Nude
3
2020
787
0.100
Why?
Carboplatin
2
2022
287
0.100
Why?
Mammary Neoplasms, Experimental
1
2011
126
0.100
Why?
Apoptosis
4
2018
1669
0.090
Why?
Class I Phosphatidylinositol 3-Kinases
2
2020
53
0.090
Why?
Methylmercury Compounds
1
2009
3
0.090
Why?
Milk, Human
1
2009
43
0.090
Why?
Hair
1
2009
56
0.090
Why?
Lymphatic Metastasis
2
2021
480
0.090
Why?
Intelligence
1
2009
71
0.090
Why?
Pyrimidines
1
2011
368
0.080
Why?
Phenotype
3
2021
2346
0.080
Why?
Aged, 80 and over
4
2019
6456
0.080
Why?
Models, Theoretical
2
2022
475
0.080
Why?
Biomarkers
2
2023
1668
0.070
Why?
Drug Administration Schedule
2
2020
917
0.070
Why?
Cytokines
2
2021
759
0.070
Why?
Endothelial Cells
2
2020
410
0.070
Why?
Cell Survival
2
2018
967
0.070
Why?
Kaplan-Meier Estimate
2
2020
856
0.070
Why?
Dose-Response Relationship, Drug
2
2020
1955
0.070
Why?
Predictive Value of Tests
2
2020
1646
0.070
Why?
Cell Cycle
2
2018
502
0.070
Why?
Quality of Life
2
2023
1507
0.070
Why?
Reproducibility of Results
2
2021
2660
0.060
Why?
Phosphatidylinositol 3-Kinases
2
2017
254
0.060
Why?
European Union
1
2023
8
0.060
Why?
Pathology, Oral
1
2023
5
0.060
Why?
Anthracyclines
1
2022
37
0.060
Why?
Adolescent
3
2022
8828
0.050
Why?
Hydroxyurea
1
2022
239
0.050
Why?
Tissue Distribution
1
2022
288
0.050
Why?
Drug Discovery
1
2023
102
0.050
Why?
Interferons
1
2022
131
0.050
Why?
Hormones
1
2022
140
0.050
Why?
Schools, Medical
1
2023
123
0.050
Why?
Albumins
1
2022
135
0.050
Why?
Switzerland
1
2021
17
0.050
Why?
Republic of Korea
1
2021
30
0.050
Why?
Histological Techniques
1
2021
35
0.050
Why?
Maximum Tolerated Dose
1
2022
271
0.050
Why?
Germany
1
2021
72
0.050
Why?
Italy
1
2021
104
0.050
Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2021
17
0.050
Why?
Models, Animal
1
2022
257
0.050
Why?
Alphapapillomavirus
1
2021
48
0.050
Why?
T Cell Transcription Factor 1
1
2021
22
0.050
Why?
United Kingdom
1
2021
163
0.050
Why?
Japan
1
2021
307
0.050
Why?
Shoulder
1
2021
39
0.050
Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
79
0.050
Why?
Induction Chemotherapy
1
2022
147
0.050
Why?
Hematoxylin
1
2020
6
0.050
Why?
Eosine Yellowish-(YS)
1
2020
10
0.050
Why?
TNF Receptor-Associated Factor 3
1
2020
2
0.050
Why?
Fluorouracil
1
2022
555
0.050
Why?
Papillomavirus E7 Proteins
1
2020
31
0.050
Why?
Patient-Specific Modeling
1
2020
19
0.050
Why?
MutL Protein Homolog 1
1
2020
33
0.050
Why?
Mismatch Repair Endonuclease PMS2
1
2020
23
0.050
Why?
MutS Homolog 2 Protein
1
2020
30
0.050
Why?
Oncogenic Viruses
1
2020
4
0.050
Why?
HCT116 Cells
1
2020
149
0.050
Why?
Drug Dosage Calculations
1
2020
16
0.050
Why?
Gene Expression Regulation, Viral
1
2020
89
0.050
Why?
Neoadjuvant Therapy
1
2022
307
0.050
Why?
Environmental Microbiology
1
2020
22
0.050
Why?
Whole Genome Sequencing
1
2020
74
0.050
Why?
Forkhead Transcription Factors
1
2021
164
0.050
Why?
Lymphocyte Depletion
1
2020
97
0.050
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2019
18
0.050
Why?
Learning
1
2023
270
0.050
Why?
Gastritis
1
2020
29
0.050
Why?
Neoplasm Invasiveness
1
2021
543
0.050
Why?
Helicobacter Infections
1
2020
34
0.050
Why?
Genetic Heterogeneity
1
2019
62
0.050
Why?
Circulating Tumor DNA
1
2020
36
0.050
Why?
Feasibility Studies
1
2022
742
0.050
Why?
Tumor Virus Infections
1
2020
81
0.050
Why?
Rad51 Recombinase
1
2020
80
0.050
Why?
Benchmarking
1
2020
78
0.050
Why?
Gene Amplification
1
2019
131
0.040
Why?
BRCA2 Protein
1
2020
147
0.040
Why?
Survivors
1
2021
221
0.040
Why?
Endothelin A Receptor Antagonists
1
2018
11
0.040
Why?
Symbiosis
1
2020
116
0.040
Why?
Central Nervous System
1
2020
151
0.040
Why?
Salivary Glands
1
2018
19
0.040
Why?
BRCA1 Protein
1
2020
190
0.040
Why?
Probiotics
1
2020
81
0.040
Why?
Primary Cell Culture
1
2018
72
0.040
Why?
Young Adult
2
2022
5861
0.040
Why?
Radiation, Ionizing
1
2019
120
0.040
Why?
MAP Kinase Kinase 4
1
2018
67
0.040
Why?
Myeloid Cells
1
2019
97
0.040
Why?
Genetic Association Studies
1
2020
290
0.040
Why?
In Situ Hybridization, Fluorescence
1
2019
348
0.040
Why?
Nasal Cavity
1
2018
91
0.040
Why?
Databases, Genetic
1
2019
259
0.040
Why?
Carcinogenesis
1
2020
190
0.040
Why?
Cadherins
1
2018
150
0.040
Why?
ROC Curve
1
2020
746
0.040
Why?
Estrogens
1
2018
196
0.040
Why?
Host-Pathogen Interactions
1
2020
227
0.040
Why?
Mice, Inbred BALB C
1
2020
1041
0.040
Why?
Time-Lapse Imaging
1
2017
19
0.040
Why?
Actins
1
2020
441
0.040
Why?
Molecular Targeted Therapy
1
2019
266
0.040
Why?
ErbB Receptors
1
2020
481
0.040
Why?
Administration, Oral
1
2018
684
0.040
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 11
1
2016
9
0.040
Why?
Patient Safety
1
2019
213
0.040
Why?
Mice, Transgenic
1
2021
1519
0.040
Why?
Pandemics
1
2023
704
0.040
Why?
Cell Self Renewal
1
2016
18
0.040
Why?
Clinical Trials as Topic
1
2022
1161
0.040
Why?
Antigens, CD
1
2018
457
0.040
Why?
Breast
1
2018
286
0.040
Why?
Cell Movement
1
2020
749
0.040
Why?
Lung
1
2023
1135
0.040
Why?
Receptors, Androgen
1
2017
108
0.040
Why?
Spiro Compounds
1
2016
25
0.040
Why?
Tissue Array Analysis
1
2016
124
0.040
Why?
Molecular Imaging
1
2017
64
0.040
Why?
Survival Analysis
1
2020
1535
0.040
Why?
Benzodiazepines
1
2016
64
0.040
Why?
CD8-Positive T-Lymphocytes
1
2020
539
0.040
Why?
Case-Control Studies
1
2021
1787
0.040
Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
114
0.040
Why?
Databases, Factual
1
2020
792
0.040
Why?
Calcium-Binding Proteins
1
2016
114
0.040
Why?
Bacteria
1
2020
436
0.040
Why?
G1 Phase
1
2016
63
0.040
Why?
CD24 Antigen
1
2015
5
0.040
Why?
Cell Adhesion Molecules
1
2016
162
0.040
Why?
Antimetabolites, Antineoplastic
1
2017
236
0.040
Why?
Heterografts
1
2016
99
0.040
Why?
Single-Cell Analysis
1
2017
126
0.030
Why?
Neprilysin
1
2015
42
0.030
Why?
Cross-Sectional Studies
1
2021
1547
0.030
Why?
Membrane Proteins
1
2022
1181
0.030
Why?
Severity of Illness Index
1
2021
1756
0.030
Why?
Cells, Cultured
1
2021
2788
0.030
Why?
Analgesics, Opioid
1
2020
398
0.030
Why?
Pyrroles
1
2016
183
0.030
Why?
Microcirculation
1
2015
103
0.030
Why?
STAT3 Transcription Factor
1
2015
74
0.030
Why?
Caspase 3
1
2015
159
0.030
Why?
Binding Sites
1
2018
1083
0.030
Why?
Random Allocation
1
2015
332
0.030
Why?
Decision Making
1
2020
632
0.030
Why?
Protein Binding
1
2018
1439
0.030
Why?
Publishing
1
2015
88
0.030
Why?
DNA Damage
1
2016
361
0.030
Why?
Immunohistochemistry
1
2018
1747
0.030
Why?
Mice, Inbred C57BL
1
2021
3050
0.030
Why?
Microscopy, Fluorescence
1
2015
420
0.030
Why?
DNA-Binding Proteins
1
2020
1202
0.030
Why?
Gastrointestinal Microbiome
1
2020
437
0.030
Why?
Child
2
2019
6763
0.030
Why?
Flow Cytometry
1
2015
673
0.030
Why?
Periodicals as Topic
1
2015
167
0.030
Why?
Internet
1
2015
309
0.030
Why?
Computer Simulation
1
2018
1064
0.030
Why?
Survival Rate
1
2017
1852
0.030
Why?
Evidence-Based Medicine
1
2015
425
0.030
Why?
Pilot Projects
1
2015
821
0.030
Why?
Incidence
1
2017
1559
0.030
Why?
Phosphorylation
1
2015
1094
0.030
Why?
Cell Differentiation
1
2018
1416
0.030
Why?
Genome-Wide Association Study
1
2020
1593
0.030
Why?
Neoplasms, Basal Cell
1
2011
9
0.030
Why?
Antibodies, Monoclonal
1
2018
1366
0.030
Why?
Genetic Predisposition to Disease
1
2019
2249
0.020
Why?
RNA Interference
1
2011
363
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2011
313
0.020
Why?
Seychelles
1
2009
2
0.020
Why?
Mercury
1
2009
8
0.020
Why?
Seafood
1
2009
10
0.020
Why?
Maternal Exposure
1
2009
56
0.020
Why?
Prostatic Neoplasms
1
2018
1685
0.020
Why?
Internship and Residency
1
2015
985
0.020
Why?
Aging
1
2009
672
0.020
Why?
Infant
1
2009
3000
0.010
Why?
Child, Preschool
1
2009
3577
0.010
Why?
Brain
1
2009
2161
0.010
Why?
Pearson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (385)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_